Ajooni Biotech last traded at ₹2.91 (2026-10-13). Over the past month the stock moved -16.9%, three months the stock moved -31.5%, year the stock moved -48.4%. Its closing range over 52 weeks is ₹2.91 – ₹5.17, with the latest close 43.7% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2010, Ajooni Biotech Ltd is a vegetarian based animal health care solutions company.[1]
Business Overview:[1] ABL is an animal health care solutions company which helps in improving the productivity of Dairy farmers and sustainably increase livestock yields. It deals in the Compounded Animal Feed and feed supplements in India and its portfolio offers a wide range of Quality Cattle feed, Cattle feed Chips, Camel Feed, Cotton Oil Cake, Mustard Oil Cake and a wide range of Feed supplements to cover the entire life-cycle of an animal.
In the latest quarter (Jun 2026), Ajooni Biotech reported sales of ₹63.49 crore (+103.0%) and net profit of ₹0.43 crore (-44.9%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 63.49 | 1.67 | 2.63 | 0.43 | 0.02 |
| Mar 2026 | 60.62 | 1.01 | 1.67 | 0.95 | 0.06 |
| Dec 2025 | 58.75 | 3.03 | 5.16 | 1.65 | 0.10 |
| Sep 2025 | 31.74 | 1.50 | 4.73 | 0.93 | 0.05 |
| Jun 2025 | 31.27 | 0.71 | 2.27 | 0.78 | 0.05 |
| Mar 2025 | 29.27 | 1.01 | 3.45 | 1.54 | 0.09 |
| Dec 2024 | 34.03 | 0.93 | 2.73 | 0.73 | 0.04 |
| Sep 2024 | 25.72 | 0.77 | 2.99 | 0.62 | 0.04 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +32.0% | +69.7% | +49.5% | +21.9% | +23.4% | +72.6% | +107.1% | +103.0% |
| Operating profit growth | +22.2% | – | -36.5% | -26.0% | +94.8% | +225.8% | +0.0% | +135.2% |
| Net profit growth | +55.0% | +65.9% | +69.2% | +66.0% | +50.0% | +126.0% | -38.3% | -44.9% |
| EPS growth | +100.0% | +33.3% | +80.0% | +66.7% | +25.0% | +150.0% | -33.3% | -60.0% |
| OPM % | 3.0% | 2.7% | 3.5% | 2.3% | 4.7% | 5.2% | 1.7% | 2.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Ajooni Biotech reported sales of ₹182.00 crore (+58.3%) and net profit of ₹4.00 crore (+33.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 182.00 | 6.00 | 3.00 | 4.00 | 0.25 |
| Mar 2025 | 115.00 | 4.00 | 3.00 | 3.00 | 0.20 |
| Mar 2024 | 80.00 | 2.00 | 3.00 | 2.00 | 0.12 |
| Mar 2023 | 74.00 | 3.00 | 4.00 | 1.00 | 0.06 |
| Mar 2022 | 74.00 | 3.00 | 4.00 | 1.00 | 0.05 |
| Mar 2021 | 51.00 | 2.00 | 3.00 | 0.00 | 0.02 |
| Mar 2020 | 40.00 | 1.00 | 3.00 | 0.00 | 0.02 |
| Mar 2019 | 40.00 | 1.00 | 2.00 | 0.00 | 0.03 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -4.8% | +0.0% | +27.5% | +45.1% | +0.0% | +8.1% | +43.8% | +58.3% |
| Operating profit growth | +0.0% | +0.0% | +100.0% | +50.0% | +0.0% | -33.3% | +100.0% | +50.0% |
| Net profit growth | – | – | – | – | +0.0% | +100.0% | +50.0% | +33.3% |
| EPS growth | +0.0% | -33.3% | +0.0% | +150.0% | +20.0% | +100.0% | +66.7% | +25.0% |
| OPM % | 2.0% | 3.0% | 3.0% | 4.0% | 4.0% | 3.0% | 3.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Ajooni Biotech.
Get Free AI Stock Analysis FREE →No recent news available for Ajooni Biotech.
Ajooni Biotech shares were last quoted at ₹2.91 (-4.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Ajooni Biotech has a price-to-earnings (P/E) ratio of 13.87 and a price-to-book (P/B) ratio of 0.60. The industry P/E is 20.57.
The 52-week high of Ajooni Biotech is ₹5.57 and the 52-week low is ₹3.02.
The market capitalisation of Ajooni Biotech is about ₹54.95 crore.
In the latest quarter (Jun 2026), Ajooni Biotech reported sales of ₹63.49 crore (+103.0%) and net profit of ₹0.43 crore (-44.9%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Ajooni Biotech has a 3-year ROE of 5.00%, 3-year profit growth of 57.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 26.89% of Ajooni Biotech.
Ajooni Biotech belongs to the Aquaculture sector.